- Review
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
- Rawan Altalhi,
- Nikoletta Pechlivani and
- Ramzi A. Ajjan
Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic pr...